Monographie - Moxifloxacin

Последно актуализиране :
08/05/2024

Moxifloxacin

Химична структура

Търговско наименование

Търговските имена са примерни и съставът на помощните вещества може да бъде различен в зависимост от държавата и лабораториите

Actira	Испания, Люксенбург, Холандия, Швеция
Avalox	Австралия, Аржентина, Белгия, Бразилия, Венецуела, Германия, Дания, Еквадор, Ирландия, Канада, Колумбия, Малайзия, Мароко, Мексико, нова Зеландия, Обединени арабски емирства, Перу, Румъния, Саудитска Арабия, Съединени Американски щати / САЩ, Турция, Унгария, Финландия, Холандия, Чили, Швеция
Axokine	Венецуела
Mahaflox	Индия
Mofelox	Турция
Mofinacin	Румъния
Moflaxa	Румъния
Moksefen	Турция
Moksilox	Турция
Moxacin	Турция
Moxifix	Турция
Moxifloxin	Белгия, Германия
Moxifloxina	Румъния
Moxifloxino	Испания, Чили
Muzdil	Испания
Octegra	Холандия, Швеция
Pixiriv	Мексико
Praiva	Еквадор, Перу
Proflox	Люксенбург

Библиография : Moxifloxacin

	Вид	Публикация
2017	Списание	Barker B, Feddema S, Rusho WJ, Dengg R. Visual compatibility of vasopressin with other injectable drugs. Am J Health-Syst Pharm 2005 ; 62: 1969-1976.
2145	Списание	Fernandez-Varon E, Marin P, Espuny A, Villamayor L, Escudero E, Carceles C. Stability of moxifloxacin injection in peritoneal dialysis solution bags (Dianeal PD1 1.36%® and Dianeal PD1 3.86%®). J Clin Pharm Ther 2006 ; 31: 641-643.
2231	Списание	de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S. Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. J Antimicrob Chemother 2008 ; 61, 2: 382-388.
2262	Списание	Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D. Compatibility of doripenem with other drugs during simulated Y-site administratioN Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
2269	Списание	Chan P, Bishop A, Kupiec TC, Trissel LA, Gole D, Jimidar IM, Vermeersch H. Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2008 ; 65, 16: 1545-1551.
3109	Лаборатория	Moxifloxacine (Izilox®) -Notice information Bayer Schering Pharma 2010
3162	Лаборатория	Moxifloxacine (Izilox®) - Résumé des caractéristiques du produits Bayer HealthCare 2010
3249	Списание	Singh BM, Dedhiya MG, Dinunzio J, Chan P, Kupiec TC, Trissel LA, Laudano JB. Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2011 ; 68: 2163-2169.
3385	Списание	Raverdi V, Ampe E, Hecq JD, Tulkens PM. Stability and compatibility of vancomycin for administration by continuous infusion. J Antimicrob Chemother 2013 ; 68: 1179-1182.
3865	Списание	Vicky M, Samit S, Jaymin P, Michael C T. Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration. Int J Pharm Compound 2016 ; 20, 3 : 236-238.
4650	Лаборатория	Ceftobiprole (Zevtera 500 mg powder for concentrate for solution for infusion.) Summary of Product Characteristics, Advanz Pharma updated 4 aug 2021. Advanz Pharma 2021
4758	Списание	Schmidt J.P, Steppe M. Stability Study and Simultaneous Determination of Norepinephrine, Moxifloxacin, and Piperacillin + Tazobactam Mixtures Applied in Intensive Care Medicine . Curr Pharm Anal 2023 ; 19, 4: 307-316.

Mentions Légales